Treatment Persistence Associated with Typical versus Atypical Antipsychotics among Out-patients with Schizophrenia
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 10, Issue 4
Abstract
Aim: The chronic nature of schizophrenia usually demands uninterrupted treatment in order to maintain optimal clinical and functional outcomes. It has been speculated that patients receiving atypical antipsychotics may persist longer in treatment than those receiving typical antipsychotics because of the lower risk of inducing extra-pyramidal symptoms. This study aimed to compare treatment persistence among patients with schizophrenia receiving atypical versus typical antipsychotics after discharge from a psychiatric hospital in Lagos, south-west Nigeria. Study Design and Methodology: A retrospective cohort study design. Clinical records of 162 patients with schizophrenia admitted to a public psychiatric hospital were extracted to determine their persistence with treatment over a period of one year after their discharge to out-patient clinic. Treatment persistence (time to all cause treatment discontinuation) was determined using the Kaplan-Meier Survival analyses. The log rank test compared persistence in treatment between patients receiving atypical versus typical antipsychotic medications. Results: Only 27.1% persisted in treatment for six months, while 19.1% persisted for one year. The mean time to all cause treatment discontinuation was 17.3 (±1.5) weeks (95% C.I= 14.4-20.3). The mean duration of treatment persistence for patients receiving typical antipsychotics was 16.7 (±2.7) weeks (95% C.I= 11.5-22.0), and 17.7 (±1.8) weeks (95% C.I= 14.2-21.2) for patients receiving atypical antipsychotics. There was no significant difference in treatment persistence between the two groups (p=0.762). Conclusion: There is a poor rate of persistence in treatment among patients with schizophrenia, regardless of the class of antipsychotics received. Considering the negative consequences of non-persistence in treatment including increased risk of relapse, re-hospitalisation and suicide, there is a dire need for interventions to facilitate treatment persistence in schizophrenia.
Authors and Affiliations
Increase Ibukun Adeosun
Keywords
Related Articles
- EP ID EP342436
- DOI 10.9734/BJPR/2016/23826
- Views 105
- Downloads 0
Effects of Ethanolic Extract of Dioscorea villosa Tubers on Male Reproductive Parameters in Wistar Rats
Aim: The current study investigates the effect of the ethanoic extract of Dioscorea villosa on male reproductive parameters using wistar rats. Study Design: Twenty four male rats were randomly sorted into 6 groups (4 rat...
The Comparative Effect of Medicinal Herb Feverfew with that of a Synthetic Parthenolide to Assess the Expression of Inducible Cyclo-oxygenase and Anti-inflammatory Activity
Aims: This paper describes the expression of inducible cyclooxygenase and anti-inflammatory of medicinal herb feverfew with a synthetic parthenolide. Study Design: In vivo model to study the expression of inducible cyclo...
Adherence to Anti-retroviral Therapy among HIV-Positive Individuals in Ghana: The Role of Stress and Post Traumatic Stress Symptoms
Aims: To identify stress and post traumatic stress symptoms (PTSS) in HIV patients on Antiretroviral therapy (ART) and further assess the possible relationship between stress, PTSS, immune function and ART medication adh...
Preliminary Efficacy Assessment of Some Selected Indigenous Plant Species of Adamawa State, Nigeria on Salmonella typhi
Aims: To screened for phytochemicals and determine the in-vitro efficacy of the plants extracts on Salmonella typhi. Study Design: Phytochemicals and in-vitro efficacy assessment of seven medicinal plants in comparison t...
Comparative Studies on Dissolution and Bioavailability of Tamoxifen Citrate Loaded Binary and Ternary Solid Dispersions
Aims: This study focused on comparing binary and ternary solid dispersions (SD's) of water-insoluble Tamoxifen citrate (TMC) regarding drug dissolution and oral bioavailability. Basically, the enhanced dissolution of thi...